Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Systemic paracrine pathways refer to the collective mechanisms of local cell-to-cell communication that occur across various organ systems to maintain physiological homeostasis (Source: Alberts B, et al., Molecular Biology of the Cell). Paracrine signaling involves the secretion of chemical messengers into the immediate extracellular environment to affect neighboring cells, which distinguishes it from endocrine signaling that acts over long distances via the bloodstream (Source: NIH National Cancer Institute). These pathways are essential for regulating immune responses, coordinating tissue repair, and managing cellular differentiation during development. In pathological states, such as the tumor microenvironment, dysregulated paracrine loops can drive disease progression by promoting angiogenesis, stromal remodeling, and immune evasion (Source: Nature Reviews Cancer). Because the term describes a general biological phenomenon and a broad category of signaling rather than a specific protein, receptor, or enzyme, it is not classified as a discrete therapeutic target.
Not applicable as this refers to a broad physiological process rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Systemic paracrine pathways.